Please login to the form below

Not currently logged in
Email:
Password:

Dr Christian Itin joins Cytos Biotechnology as CEO

He moves to the Swiss biotech from Micromet

Cytos Biotechnology CEO Dr Christian ItinSwiss biotech company Cytos Biotechnology has appointed Dr Christian Itin to be its new CEO.

He has also been elected to Cytos' board of directors and will be proposed as its new chairman, succeeding Dr Thomas Hecht, at an extraordinary shareholders meeting next month.

Dr Itin joins Cytos from Micromet, where he served as CEO for eight years until the biopharmaceutical company was acquired by Amgen earlier this year for $1.2bn.

In total he spent 13 years in senior management roles at Micromet, prior to which he co-founded US protein chip company Zyomyx.

Commenting on the appointment Dr Hecht said: “Christian is an experienced biotech leader with significant expertise and a proven track record and his appointment completes our restructuring of Cytos. We believe with his experience and skills that he is well positioned to shape Cytos' future.” 

Cytos' board will see a further change next month, when non-executive member, and its former chief financial officer Jakob Schlapbach will set down at the shareholder meeting.

18th October 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics